Mind Medicine (MindMed) Inc.

NASDAQ:MNMD

7.32 (USD) • At close December 24, 2024
Bedrijfsnaam Mind Medicine (MindMed) Inc.
Symbool MNMD
Munteenheid USD
Prijs 7.32
Beurswaarde 536,787,942
Dividendpercentage 0%
52-weken bereik 3.49 - 12.22
Industrie Biotechnology
Sector Healthcare
CEO Mr. Robert Barrow
Website https://www.mindmed.co

An error occurred while fetching data.

Over Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the

Vergelijkbare Aandelen

Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation

ABUS

3.18 USD

Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc.

OTLK

1.47 USD

Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc.

RIGL

16.44 USD

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

9.87 USD

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

77.58 USD

Athira Pharma, Inc. logo

Athira Pharma, Inc.

ATHA

0.542 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

4.55 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

0.351 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)